Related Experiment Video
Updated: Oct 31, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Novel pathogenic variant of MYBPC3 responsible for hypertrophic cardiomyopathy
Xiaofei Yang1,2, Zhenghao Li1, Qingfa Wang1
1Department of Pediatrics, Yidu Central Hospital of Weifang, Weifang, Shandong, China.
Insights
A novel MYBPC3 gene variant (p.E911X) causes diverse hypertrophic cardiomyopathy phenotypes. Whole-exome sequencing aids in early screening and diagnosis of this genetic heart condition.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
- Identifying pathogenic gene variants is crucial for understanding disease mechanisms and inheritance patterns.
Purpose of the Study:
- To identify the pathogenic gene variant in a family with hypertrophic cardiomyopathy using whole-exome sequencing.
- To correlate the identified gene variant with the clinical phenotypes observed in family members.
Main Methods:
- Whole-exome sequencing (WES) was performed on DNA from a family affected by HCM.
- Sanger sequencing confirmed the identified variant.
- Bioinformatics tools predicted the functional impact of the variant.
- Clinical data from family members were analyzed.
Main Results:
- A novel heterozygous nonsense variant, MYBPC3:c.2731G > T (p.E911X), was identified in the proband.
- The variant affects conserved amino acids and alters the MYBPC3 protein structure, including domain incompleteness and deletions.
- Clinical data revealed diverse phenotypes among variant carriers, indicating functional protein damage.
Conclusions:
- The novel MYBPC3 variant (p.E911X) leads to variable severity and clinical manifestations of hypertrophic cardiomyopathy.
- Whole-exome sequencing is effective for comprehensive screening of HCM-associated genes, supporting early diagnosis and treatment strategies, particularly in children.
Objectives:
This study aims to investigate the pathogenic gene variant in a family with hypertrophic cardiomyopathy by using whole-exome sequencing and to explore the relationship between the gene variant and clinical phenotype.
Methods:
Peripheral blood was collected from a family with hypertrophic cardiomyopathy, and deoxyribonucleic acid was extracted. The possible pathogenic genes were detected by whole-exome sequencing, and the variant was verified by Sanger sequencing. Functional change in the variant was predicted by bioinformatics software. Clinical data of the family members are analysed simultaneously.
Results:
The proband carries a novel heterozygous nonsense variant of MYBPC3:c.2731G > T (p.E911X). The analysis of amino acid conservation suggests that the variation is highly conserved. The three-dimensional protein structure shows that the variant in MYBPC3 results in the incompleteness of the fibronectintype-III2 (p872-967) domain and deletion of Ig-like C2-type 6 (p971-1065) and fibronectin type-III 3 and Ig-like C2-type 7 (p1181-1274) domains, in which p1253-1268 is predicted to have a transmembrane helix structure. Clinical data indicate that the phenotypes of variant carriers with hypertrophic cardiomyopathy are diverse, suggesting the functional damages to the protein of MYBPC3.
Conclusion:
The phenotypes of variant carriers with hypertrophic cardiomyopathy caused by the novel variant in MYBPC3: c.2731G > T (p.E911X) exhibit variable severity and clinical manifestations. Whole-exome sequencing can be used to comprehensive screen hypertrophic cardiomyopathy genes and provide a strong basis for early screening and accurate diagnosis and treatment of hypertrophic cardiomyopathy in children.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Myocarditis I: Introduction

